{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:06:20Z","timestamp":1791133580949,"version":"4.1.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.critrevonc.2004.11.010","type":"journal-article","created":{"date-parts":[[2005,6,27]],"date-time":"2005-06-27T21:07:06Z","timestamp":1119906426000},"page":"71-85","source":"Crossref","is-referenced-by-count":108,"title":["Cancer incidence after immunosuppressive treatment following kidney transplantation"],"prefix":"10.1016","volume":"56","author":[{"given":"Amado","family":"Andr\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2004.11.010_bib1","first-page":"2154","article-title":"Twenty and 25 years survival after cadaveric renal transplantation","volume":"27","author":"Mahony","year":"1995","journal-title":"Transplant Proc"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00002018-200023020-00002","article-title":"Post-transplant malignancy: the role of immunosuppression","volume":"23","author":"Penn","year":"2000","journal-title":"Drug Saf"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib4","first-page":"147","article-title":"Occurrence of cancers in immunosuppressed organ transplant recipients","volume":"1","author":"Penn","year":"1998","journal-title":"Clin Transplant"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib5","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0041-1345(98)01987-3","article-title":"Posttransplant malignancies","volume":"31","author":"Penn","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib6","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/S0140-6736(00)02298-4","article-title":"Cancer risk in patients on dialysis and after renal transplantation","volume":"355","author":"Birkeland","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(05)79544-1","article-title":"Effect of two cyclosporin regimens on cancer frequency in kidney-graft recipients","volume":"352","author":"Birkeland","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib8","first-page":"22","article-title":"De novo cancers complicating renal transplantation: experience in the Nordic countries","volume":"2","author":"Birkeland","year":"1997","journal-title":"Ann Transplant"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ijc.2910600209","article-title":"Cancer risk after renal transplantation in the Nordic countries, 1964\u20131986","volume":"60","author":"Birkeland","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib10","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0041-1345(98)01988-5","article-title":"Patterns of malignancies following renal transplantation","volume":"31","author":"Sheil","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib11","first-page":"1275","article-title":"Development of malignancy following renal transplantation in Australia and New Zealand","volume":"24","author":"Sheil","year":"1992","journal-title":"Transplant Proc"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib12","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0041-1345(96)00151-0","article-title":"Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation","volume":"29","author":"Sheil","year":"1997","journal-title":"Transplant Proc"},{"issue":"Suppl. 1","key":"10.1016\/j.critrevonc.2004.11.010_bib13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/ndt\/10.supp1.74","article-title":"Malignancies after renal transplantation: the EDTA-ERA registry experience. European Dialysis and Transplantation Association-European Renal Association","volume":"10","author":"Brunner","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(99)06154-1","article-title":"Cancer in patients on dialysis for end-stage renal disease: an international collaborative study","volume":"354","author":"Maisonneuve","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/01.ASN.0000039608.81046.81","article-title":"Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand","volume":"14","author":"Stewart","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib16","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1136\/jcp.30.9.868","article-title":"Acquired cystic disease of the kidneys: a hazard of long-term intermittent maintenance haemodialysis","volume":"30","author":"Dunnill","year":"1977","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib17","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0041-1345(03)00618-3","article-title":"Results of kidney transplantation in recipients over 70 years of age: experience at a single center","volume":"35","author":"Herrero","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib18","first-page":"14","article-title":"Evaluation of transplant candidates with pre-existing malignancies","volume":"2","author":"Penn","year":"1997","journal-title":"Ann Transplant"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib19","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/00007890-199304000-00011","article-title":"The effect of immunosuppression on pre-existing cancers","volume":"55","author":"Penn","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib20","first-page":"1","article-title":"European Best Practice Guidelines for Renal Transplantation (part 1)","volume":"15","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1681\/ASN.V611","article-title":"The evaluation of renal transplant candidates: clinical practice guidelines. Patient Care and Education Committee of the American Society of Transplant Physicians","volume":"6","author":"Kasiske","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib22","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0041-1345(00)02698-1","article-title":"Recurrence of cancer after renal transplantation","volume":"33","author":"Chapman","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib23","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/00007890-200105270-00021","article-title":"Screening for solid organ malignancies prior to heart transplantation","volume":"71","author":"Conraads","year":"2001","journal-title":"Transplant Proc"},{"issue":"Suppl. 15","key":"10.1016\/j.critrevonc.2004.11.010_bib24","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1681\/ASN.V11suppl_1s1","article-title":"Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation","volume":"11","author":"Kasiske","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib25","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1034\/j.1600-6143.2003.00118.x","article-title":"Screening for prostate, breast and colorectal cancer in renal transplant recipients","volume":"3","author":"Kiberd","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib26","first-page":"7","article-title":"Transmission of cancer from organ donors","volume":"2","author":"Penn","year":"1997","journal-title":"Ann Transplant"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib27","first-page":"205","article-title":"Transmission of cancer from organ donors","volume":"15","author":"Penn","year":"1995","journal-title":"Nefrologia"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib28","first-page":"91","article-title":"Estandarizaci\u00f3n en los criterios de donaci\u00f3n de \u00f3rganos para prevenir la transmisi\u00f3n de enfermedades neopl\u00e1sicas","volume":"21","author":"Fernandez Lucas","year":"2001","journal-title":"Nefrologia"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib29","unstructured":"International Consensus Document Standardization of Organ Donor Screening to Prevent Transmission of Neoplastic Diseases. Select Committee of Expert in the Organisational Aspects of Cooperation in Organ Transplantation, Council of Europe. Transplant Newslett., 1997;2."},{"key":"10.1016\/j.critrevonc.2004.11.010_bib30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/1097-0142(19800101)45:1<112::AID-CNCR2820450121>3.0.CO;2-9","article-title":"Extraneural metastases of astrocytomas and glioblastomas: clinicopathological study of two cases and review of literature","volume":"45","author":"Pasquier","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib31","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/1097-0142(19811115)48:10<2296::AID-CNCR2820481028>3.0.CO;2-C","article-title":"Systemic metastases from medulloblastoma: report of two cases and review of the literature","volume":"48","author":"Kleinman","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib32","first-page":"2242","article-title":"Transmission of medulloblastoma from cadaver donor to three organ transplant recipients","volume":"19","author":"Lefrancois","year":"1987","journal-title":"Transplant Proc"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib33","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00007890-199011000-00026","article-title":"Development of a malignant tumor in a liver transplant graft procured from a donor with a cerebral neoplasm","volume":"50","author":"Morse","year":"1990","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib34","first-page":"682","article-title":"Transmission of glioblastoma multiforme to two kidney transplant recipients from the same donor in the absence of ventricular shunt","volume":"55","author":"Ruiz","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib35","first-page":"3075","article-title":"Transmission of non-Hodgkin's lymphoma through renal allografts\u2014disastrous result of false diagnosis and inadequate information","volume":"25","author":"Konigsrainer","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib36","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/00007890-199403270-00034","article-title":"Transmission of CNS malignancy by organ transplantation","volume":"57","author":"Colquhoun","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib37","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1432-2277.1996.tb00903.x","article-title":"Liver graft-transmitted glioblastoma multiforme. A case report and experience with 13 multiorgan donors suffering from primary cerebral neoplasia","volume":"9","author":"Jonas","year":"1996","journal-title":"Transplant Int"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib38","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0041-1345(96)00156-X","article-title":"Interferon-alpha and the cure of metastasis of a malignant meningioma in a kidney allograft recipient: a case report","volume":"29","author":"Bosmans","year":"1997","journal-title":"Transplant Proc"},{"issue":"9121","key":"10.1016\/j.critrevonc.2004.11.010_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(98)24027-X","article-title":"Transmission of glioblastoma multiforme through liver transplantation","volume":"352","author":"Frank","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib40","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/01.TP.0000076094.64973.D8","article-title":"Donors with central nervous system malignancies: are they truly safe?","volume":"76","author":"Buell","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib41","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00007890-200202270-00017","article-title":"Transplant tumor registry: donors with central nervous system tumors1","volume":"73","author":"Kauffman","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib42","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/S0041-1345(98)01989-7","article-title":"Risk of tumor transmission in transplantation from donors with primary brain tumors: an Australian and New Zealand registry report","volume":"31","author":"Chui","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib43","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/00007890-200012270-00014","article-title":"First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer","volume":"70","author":"Kauffman","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib44","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00007890-200208150-00011","article-title":"Transplant tumor registry: donors related malignancies","volume":"74","author":"Kauffman","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib45","first-page":"214","article-title":"Trasmisi\u00f3n de enfermedades neoplasicas de donantes de \u00f3rganos s\u00f3lidos: la experiencia espa\u00f1ola 1990\u20132000","volume":"9","author":"Fernandez-Zinke","year":"2000","journal-title":"Rev Esp Trasp"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib46","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00007890-200211270-00012","article-title":"Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors","volume":"74","author":"Birkeland","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib47","first-page":"147","article-title":"Donors\u2019 selection: organs viability criteria","volume":"3","author":"Andres","year":"2001","journal-title":"Organ Tissues"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib48","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1034\/j.1399-0012.2003.00119.x","article-title":"Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing organ pool","volume":"17","author":"Lopez-Navidad","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib49","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0041-1345(03)00691-2","article-title":"Prostate-specific antigen in the assessment of organ donors","volume":"35","author":"Frutos","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib50","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/jama.277.2.133","article-title":"Development of donor-derived prostate cancer in a recipient following orthotopic heart transplantation","volume":"277","author":"Loh","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib51","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1097\/01.ju.0000116431.65651.58","article-title":"Evaluation and selection of potential live kidney donors","volume":"171","author":"Wafa","year":"2004","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.critrevonc.2004.11.010_bib52","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1600-6143.2004.00450.x","article-title":"Cancer after kidney transplantation in the United States","volume":"4","author":"Kasiske","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib53","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0140-6736(95)91618-0","article-title":"Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation","volume":"346","author":"Stewart","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib54","series-title":"Kidney Transplantation. Principles and Practice","first-page":"558","article-title":"Cancer in dialysis and transplant patients","author":"Sheil","year":"2001"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib55","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.bjc.6601219","article-title":"Cancer risk following organ transplantation: a nationwide cohort study in Sweden","volume":"89","author":"Adami","year":"2003","journal-title":"Br J Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.critrevonc.2004.11.010_bib56","first-page":"85","article-title":"Canceres en receptores de trasplante: ensayo de estudio cooperativo espa\u00f1ol","volume":"13","author":"Lampreabe","year":"1993","journal-title":"Nefrologia"},{"issue":"Suppl. 1","key":"10.1016\/j.critrevonc.2004.11.010_bib57","doi-asserted-by":"crossref","first-page":"S394","DOI":"10.1111\/j.1432-2277.2000.tb02068.x","article-title":"Cancer incidence in a kidney-transplanted population","volume":"13","author":"Kyllonen","year":"2000","journal-title":"Transplant Int"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib58","first-page":"124","article-title":"Cancer after transplantation in Catalonia","volume":"24","author":"Vilardell","year":"1992","journal-title":"Transplant Proc"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib59","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/(SICI)1097-0215(19970516)71:4<517::AID-IJC3>3.0.CO;2-X","article-title":"Cancer risk after renal transplantation in Japan","volume":"71","author":"Hoshida","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib60","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0041-1345(96)00153-4","article-title":"Malignancy after renal transplantation: analysis of incidence and risk factors in 1700 patients followed during a 25-year period","volume":"29","author":"Hiesse","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib61","first-page":"3201","article-title":"A parametric analysis of the hazard of cancer after transplantation","volume":"21","author":"Mankin","year":"1989","journal-title":"Transplant Proc"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib62","first-page":"42","article-title":"Incidencia y tratamiento de neoplasias despu\u00e9s del trasplante renal","volume":"15","author":"Anaya","year":"1995","journal-title":"Nefrologia"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib63","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1097\/00007890-199912270-00008","article-title":"Risk factors for cancer in renal transplant recipients","volume":"68","author":"Danpanich","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib64","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0041-1345(96)00154-6","article-title":"Malignancies in patients under long-term immunosuppression after kidney transplantation","volume":"29","author":"Behrend","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib65","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0041-1345(00)01487-1","article-title":"Clinical study of malignancies after renal transplantation and impact of routine screening for early detection: a single-center experience","volume":"32","author":"Ishikawa","year":"2000","journal-title":"Transplant Proc"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib66","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/00365599609181310","article-title":"Malignant tumours after renal transplantation","volume":"30","author":"Fahlenkamp","year":"1996","journal-title":"Scand J Urol Nephrol"},{"issue":"Suppl. 5","key":"10.1016\/j.critrevonc.2004.11.010_bib67","first-page":"52","article-title":"Incidencia de neoplasias no derivadas de la epidermis en pacientes con trasplante renal","volume":"22","author":"Villacampa","year":"1998","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib68","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/BF02574501","article-title":"Mlignancy after renal transplantation: incidence and role of type of immunosuppression","volume":"9","author":"Tremblay","year":"2002","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib69","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(95)92780-8","article-title":"Risk of neoplasia in renal transplant patients","volume":"346","author":"London","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib70","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000281722","article-title":"Cancer incidence in patients on chronic dialysis and in renal transplant recipients","volume":"45","author":"Pecqueux","year":"1990","journal-title":"Urol Int"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib71","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000282871","article-title":"Tumors after renal transplantation","volume":"57","author":"Schmidt","year":"1996","journal-title":"Urol Int"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib72","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1023\/A:1007194607496","article-title":"The incidence of tumours in renal transplant recipients with long-term immunosuppressive therapy","volume":"31","author":"Ondrus","year":"1999","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib73","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/ndt\/5.4.282","article-title":"Malignant tumours in renal transplant recipients receiving cyclosporin: survey of 598 first-kidney transplantations","volume":"5","author":"Vogt","year":"1990","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib74","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1097\/00007890-199506270-00011","article-title":"Malignant disease in patients with long-term renal transplants","volume":"59","author":"Gaya","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib75","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(97)08496-1","article-title":"Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens","volume":"351","author":"Dantal","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib76","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0022-5347(17)39354-0","article-title":"Outcome of renal transplantation in patients with a functioning graft for 20 years or more","volume":"144","author":"Slavis","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib77","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1046\/j.1600-6143.2003.00245.x","article-title":"Tumors and transplantation: the 2003 Third Annual ASTS State-of-the-Art Winter Symposium","volume":"3","author":"Feng","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib78","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00007890-199603150-00008","article-title":"The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study","volume":"61","author":"Bouwes Bavinck","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib79","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev.med.46.1.381","article-title":"Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: implications for understanding their pathogenesis and developing rational treatment strategies","volume":"46","author":"Hanto","year":"1995","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib80","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0041-1345(98)01990-3","article-title":"Lymphoproliferative disease in children","volume":"31","author":"Harmon","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib81","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/clinids\/20.5.1346","article-title":"Pretransplantation assessment of the risk of lymphoproliferative disorder","volume":"20","author":"Walker","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib82","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00007890-199307000-00016","article-title":"Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center","volume":"56","author":"Cockfield","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib83","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/00007890-199312000-00023","article-title":"Epstein-Barr virus serology and Epstein-Barr virus-associated lymphoproliferative disorders in pediatric liver transplant recipients","volume":"56","author":"Sokal","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib84","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0140-6736(05)80084-4","article-title":"Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients","volume":"342","author":"Opelz","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib85","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib86","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0041-1345(98)01992-7","article-title":"Cancer risk associated with ATG\/OKT3 in renal transplantation","volume":"31","author":"Hibberd","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib87","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1600-6135.2003.00274.x","article-title":"Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients","volume":"4","author":"Bustami","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib88","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJM199012203232502","article-title":"Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients","volume":"323","author":"Swinnen","year":"1990","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.critrevonc.2004.11.010_bib89","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/rr.2000.5269","article-title":"Cancers in renal transplant recipients","volume":"7","author":"Penn","year":"2000","journal-title":"Adv Ren Replace Ther"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib90","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1097\/00007890-199911270-00015","article-title":"Epstein-Barr virus-induced post-transplant lymphoproliferative disorders ASTS\/AST EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting","volume":"68","author":"Paya","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib91","unstructured":"Sayegh MH, Eisen HJ, Brennan DC, Friedberg JP. Lymphoproliferative disorders following solid organ transplantation. In Rose BD ed. UptoDate in Nephrology and Hypertension version 12.2 Renal transplant section www.uptodate.com Wellesley MA, USA 2004."},{"key":"10.1016\/j.critrevonc.2004.11.010_bib92","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1016\/S0041-1345(01)02577-5","article-title":"Israel Penn International Transplant Tumor Registry. Kaposi sarcoma: an analysis of the US and international experiences from the Israel Penn International Transplant Tumor Registry","volume":"33","author":"Woodle","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib93","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMra022137","article-title":"Skin cancers after organ transplantation","volume":"348","author":"Euvrard","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib94","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/01.TP.0000115344.18025.0B","article-title":"Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma","volume":"77","author":"Campistol","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib95","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/00007890-199559040-00006","article-title":"Primary kidney tumors before and after renal transplantation","volume":"59","author":"Penn","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib96","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0041-1345(98)01993-9","article-title":"Hepatocellular carcinoma after kidney transplantation","volume":"31","author":"Jeng","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib97","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1097\/00007890-200205270-00008","article-title":"Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy","volume":"73","author":"Luan","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2004.11.010_bib98","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1046\/j.1523-1755.2003.00805.x","article-title":"Rapamycin is an effective inhibitor of human renal cancer metastasis","volume":"63","author":"Luan","year":"2003","journal-title":"Kidney Int"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842805000879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842805000879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T11:41:00Z","timestamp":1626090060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842805000879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S1040842805000879"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2004.11.010","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}